Medical Weight Loss for Skokie, Illinois Residents

Skokie, Illinois residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Skokie through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Follow-up that stays with you in Skokie: your care does not end at the first visit, Dr. Sharma and our team check in by secure video as you progress, no matter where you are in Illinois. Results vary. Doctor review just $119 (medication separate).

Why Skokie Residents Choose New Hope Weight Loss

For Skokie patients who want a doctor genuinely involved, this is the right fit. Compounded semaglutide and tirzepatide are powerful tools, but they are not for everyone, and Dr. Anjmun Sharma treats them that way. She looks at your labs, your medications, and your goals before anything is prescribed, then keeps adjusting as your body responds. These medications are not FDA-approved and results vary, which is exactly why physician oversight matters this much.

From our Costa Mesa, California practice, we provide Skokie with physician-supervised GLP-1 care entirely by telehealth. Treatment is prescribed only after Dr. Sharma's review, and medication ships discreetly to your door.

People throughout Skokie reach the same physician-supervised care that built our reputation in Costa Mesa, and they do it from home, because telehealth erases the gap between Illinois and California. We care for patients throughout downtown Skokie and the North Shore suburbs of Cook County. Your plan is shaped around your own history, the medications you have tried, and the goals you bring, not a one-size template applied to every Skokie patient.

Treatment is supervised by the same physician for all of Illinois, which means your distance from Costa Mesa changes nothing about your care or your cost. If you and Dr. Sharma decide tirzepatide fits your goals, Skokie patients can begin from $233 per month, billed apart from your initial $119 visit. From the big cities to the small towns of Illinois, New Hope Weight Loss provides physician-supervised GLP-1 care by secure telehealth from our Costa Mesa, California clinic.

GLP-1 Weight Loss Programs Available

Compounded GLP-1 care, supervised by a physician

The 90-Day Metabolic Reset is built on semaglutide, the same active ingredient you will find in Wegovy and Ozempic. It is priced from $166/mo, with the complete 90-day program at $499, and branded-drug trials averaged about 15 to 17 percent body-weight loss. Compounded semaglutide is not FDA-approved, not brand-identical, and results vary by person. Dr. Sharma manages your care by telehealth, wherever you are in Skokie.

Prefer the dual-action route? Tirzepatide

From $233/mo, tirzepatide works on GLP-1 and GIP together. In branded-drug trials, dose-qualified patients reached up to 22.5 percent loss, a peak number that is not typical. Same active ingredient as Mounjaro and Zepbound.

It all starts with a $119 physician review. Medication billed separately. HSA, FSA, Klarna, and Affirm accepted.

How Telehealth Works for Skokie

Here is how the whole thing works, start to finish, for anyone in Skokie.

First, you fill out an intake and quiz about your weight history and current health. Next, Dr. Sharma looks it over and meets you by secure video, almost always within 48 hours, to see whether compounded semaglutide or tirzepatide fits your situation. Then, if she prescribes, a state-licensed 503(a) pharmacy ships the medication to your Skokie address in cold-pack packaging built to protect it on the road. After that, every follow-up is a video visit, so the care continues no matter where you are in .

Frequently Asked Questions, Skokie

I am searching for weight loss care near Skokie. Where are you?

We are based in Costa Mesa, California, where our only physical clinic operates. Patients in Skokie, Illinois connect with us by telehealth instead of visiting. Dr. Anjmun Sharma conducts a video consult to review your goals and confirm whether you qualify for a compounded GLP-1 medication program.

Do I need to be seen in person if I live in Skokie?

Not at all. The telehealth format covers Skokie patients from start to finish, so no clinic visit is ever required. You speak with Dr. Sharma by video, and once you are approved, compounded medication ships to Skokie in cold-pack packaging built to keep it cool and stable.

What are the program costs for Skokie patients?

The physician review is priced at $119. Compounded semaglutide is available from $166 a month or $499 for the 90-day plan, and tirzepatide from $233 a month. Medication is invoiced separately. Payment options include HSA, FSA, Klarna, and Affirm, and Skokie patients face no distance surcharge.

What areas of Skokie do you serve?

We serve patients from across Skokie by telehealth, including downtown Skokie and the North Shore suburbs of Cook County.

How does telehealth treatment work for Skokie patients?

You complete the online medical intake, Dr. Sharma reviews your history by secure video, typically within 48 hours, and if you are a candidate and telehealth-eligible, compounded medication ships to your Skokie address. Follow-ups also happen by video.

Skokie Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Skokie, Illinois by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.